PPP2R5A and malignant colon neoplasm: However, overexpression of both the wt and the R112L mutated version of PPP2R5A (Fig. 5a–c) had a similar negative impact on colon cancer cell growth and did not alter CET treatment sensitivity (Fig. 5d).